102 related articles for article (PubMed ID: 25834916)
41. A case of ovarian serous adenocarcinoma suggestive of transformation to an AFP-producing tumor during chemotherapy.
Kataoka A; Nishida T; Sugiyama T; Yakushiji M
J Obstet Gynaecol (Tokyo 1995); 1995 Oct; 21(5):451-9. PubMed ID: 8542468
[TBL] [Abstract][Full Text] [Related]
42. Targeted therapy in the treatment of uterine serous carcinoma.
Schwab CL; Santin AD
Pharmacogenomics; 2015 Jan; 16(2):97-9. PubMed ID: 25616096
[No Abstract] [Full Text] [Related]
43. Targeting the mitogen-activated protein kinase pathway in low-grade serous carcinoma of the ovary.
McLachlan J; Gore M; Banerjee S
Pharmacogenomics; 2016 Aug; 17(12):1353-63. PubMed ID: 27469379
[TBL] [Abstract][Full Text] [Related]
44. [The evaluation of the efficacy of adjuvant laferon therapy in the combined treatment of patients with ovarian cancer based on the monitoring of the tumor marker Ca-125 in the blood serum].
Zhyl'chuk VIe; Alistratov OV; Vorontsova AL
Lik Sprava; 1998; (2):137-9. PubMed ID: 9670686
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy of ovarian cancer. New approaches to treatment.
Smith JP; Rutledge F; Wharton JT
Cancer; 1972 Dec; 30(6):1565-71. PubMed ID: 4345098
[No Abstract] [Full Text] [Related]
46. Hilus Cell Heterotopia With Intraneural Eutopia.
Chougule A; Dey P
Int J Gynecol Pathol; 2017 Mar; 36(2):200-202. PubMed ID: 27309617
[No Abstract] [Full Text] [Related]
47. Low-grade Serous Tumors: Are We Making Progress?
Pauly N; Ehmann S; Ricciardi E; Ataseven B; Bommert M; Heitz F; Prader S; Schneider S; du Bois A; Harter P; Baert T
Curr Oncol Rep; 2020 Jan; 22(1):8. PubMed ID: 31989304
[TBL] [Abstract][Full Text] [Related]
48. [Experimental chemotherapy of ovarian cancers heterotransplanted in nude mice].
Sawada M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Aug; 37(8):1400-8. PubMed ID: 2995515
[No Abstract] [Full Text] [Related]
49. Update on nonserous ovarian cancer trials.
Fujiwara K; Yoshida H; Hasegawa K
Ann Oncol; 2013 Dec; 24 Suppl 10():x46-x47. PubMed ID: 24265404
[No Abstract] [Full Text] [Related]
50. Use of in vitro method to predict response of human ovarian carcinoma cells to chemotherapeutic agents.
Buckshee K; Roy PK; Chapekar TN
Int J Gynaecol Obstet; 1984 Oct; 22(5):371-4. PubMed ID: 6151922
[TBL] [Abstract][Full Text] [Related]
51. Ethics of chemotherapy during pregnancy.
Fancher KM; Giannetti V; McLaughlin BT
Am J Health Syst Pharm; 2019 Feb; 76(4):242-246. PubMed ID: 30715184
[No Abstract] [Full Text] [Related]
52. [Treatment of ovarian clear cell carcinoma].
Mabuchi S; Takahashi R; Sasano T; Kuroda H; Kimura T
Gan To Kagaku Ryoho; 2015 Feb; 42(2):174-8. PubMed ID: 25834915
[No Abstract] [Full Text] [Related]
53. Real-time ultrasonographically guided transvaginal instillation for intraperitoneal chemotherapy of ovarian carcinoma.
Yamaguchi H; Ito M; Toyoda N
Gynecol Oncol; 2000 Nov; 79(2):332-5. PubMed ID: 11063668
[TBL] [Abstract][Full Text] [Related]
54. [Recent process of molecular target therapies in ovarian serous and endometrioid carcinomas on basis of intergrated genomic characterization].
Oda K
Gan To Kagaku Ryoho; 2015 Feb; 42(2):169-73. PubMed ID: 25834914
[No Abstract] [Full Text] [Related]
55. p16 as a prognostic indicator in ovarian/tubal high-grade serous carcinoma.
Beirne JP; McArt DG; James JA; Salto-Tellez M; Maxwell P; McCluggage WG
Histopathology; 2016 Mar; 68(4):615-8. PubMed ID: 26173002
[No Abstract] [Full Text] [Related]
56. [Effect of Thio-TEPA on advanced ovarian cancer (author's transl)].
Luciani L; De Palo GM; Conti U; Mattavelli F; Di Re F
Tumori; 1973; 59(4):259-67. PubMed ID: 4357004
[No Abstract] [Full Text] [Related]
57. MicroRNA regulation of RAD51 in serous ovarian cancer modulates chemotherapy response.
Wiemer EA; Berns EM
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25995443
[No Abstract] [Full Text] [Related]
58. IV. Current Status and Future Perspectives in Low-Grade Serous Cancer of the Ovary.
Siemon J; Gershenson D; Slomovitz B; Schlumbrecht M
Gan To Kagaku Ryoho; 2018 Feb; 45(2):247-255. PubMed ID: 29483415
[No Abstract] [Full Text] [Related]
59. New Insight into Mucinous Ovarian Cancer.
Cancer Discov; 2015 Sep; 5(9):900. PubMed ID: 26156090
[No Abstract] [Full Text] [Related]
60. [Impact of molecular classification on clinical management of ovarian cancer].
Hasegawa K
Gan To Kagaku Ryoho; 2015 Feb; 42(2):166-8. PubMed ID: 25834913
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
